Wockhardt under NPPA lens over essential blood pressure medicine price
The medicines in question are methyldopa 250 mg and methyldopa 500 mg and both of these are currently under price control. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news

CDSCO flags drug firms for making and selling combination medicines without approval
Over 70 fixed dose combination (FDC) medicine brands marketed by 16 pharma companies have been seized in an ongoing raid of two drug manufacturing facilities. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets 4 observations from USFDA for Telangana plant
US health regulator has issued four observations after inspecting Dr Reddy's active pharmaceutical ingredients (API) facility in Telangana. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches allergy relief tablets in US
Levocetirizine dihydrochloride tablets are used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose and sneezing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2018 Category: Pharmaceuticals Source Type: news

CDSCO to create forum to discuss "various issues" pertaining to drug regulations
The meetings will further help the CDSCO assess the impact of its regulations on the industry and is also expected to help promote innovation, according to the official. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2018 Category: Pharmaceuticals Source Type: news

Bayer Pharmaceuticals committed to India growth; to push for more R & D
"Asia Pacific is the fastest growing region for Bayer's pharmaceuticals sales globally. We are very interested and committed to India and are very successful with our combined product portfolio through our joint venture Bayer Zydus Pharma in India," Claus Zieler said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2018 Category: Pharmaceuticals Source Type: news

Strides Shasun gets USFDA nod for HIV treatment drug
The product will be manufactured at the company's oral dosage facility at Bangalore and will be marketed by Strides Pharma Inc in the US market, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 14, 2018 Category: Pharmaceuticals Source Type: news

Unichem Labs under regulator scanner for launching blood pressure medicines without price approval
According to NPPA, Unichem launched these medicines over four years before it applied to the regulator for price fixation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2018 Category: Pharmaceuticals Source Type: news

Glenmark to divest orthopedic brand portfolio; strategic suitors line up
"Glenmark is looking to sell its portfolio of brands in the orthopedic segment to raise funds in a bid to reduce its debt and invest funds in its US business," said one of the sources. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2018 Category: Pharmaceuticals Source Type: news

Prices of 851 essential drug formulations cut in past 2 year: Government
In a written reply to the Lok Sabha, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said the government has cut the prices of 234 essential drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for Tizanidine tablets
The approval by the US Food and Drug Adminstration is for multiple strengths of 2 mg and 4 mg, the company said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2018 Category: Pharmaceuticals Source Type: news

India to create new essential list to improve access to life-saving diagnostic tests
At a later stage, the list is expected to even bring down prices of these tests in the private sector, according to a senior government official close to the development. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2018 Category: Pharmaceuticals Source Type: news

USFDA team finds 'female mosquito' in Aurobindo Pharma's facility during inspection
The American health regulator has issued nine observations after inspecting the drug maker's Unit 4 formulation facility near Hyderabad in southern India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2018 Category: Pharmaceuticals Source Type: news

Health sector could create jobs on massive scale: Public Health Foundation of India
K Srinath Reddy, who cited a 2016 UN report, said the country needs to invest in the training and skilling of youth so that they can become world class professionals. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2018 Category: Pharmaceuticals Source Type: news

Microsoft, Apollo Hospitals join hands to improve cardiac care
The partnership between Microsoft and Apollo will work to develop and deploy new machine learning models to predict patient risk for heart disease and assist doctors on treatment plans, (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2018 Category: Pharmaceuticals Source Type: news

WHO invites applications from drug companies for pre-qualification of MDR TB drugs
WHO said the expression of interest will be evaluated on the basis of product dossiers, which must include product data and information as specified in the guidelines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 7, 2018 Category: Pharmaceuticals Source Type: news

The tightrope walk of India's drug-price regulator
ET Online retraces here the tenures of NPPA chiefs. The question to ask: Is taking on the pharma and healthcare lobby injurious to the NPPA boss? (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 6, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma's unit gets 9 USFDA observations
USFDA has conducted an inspection at the company's unit 4, a formulation manufacturing facility in Hyderabad from February 12 to February 20, 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 5, 2018 Category: Pharmaceuticals Source Type: news

Last chance for medical devices firms to submit price data: NPPA
The devices include catheters, heart valves, orthopaedic implants, disposable hypodermic syringes and needles, surgical dressings and internal prosthetic replacements. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2018 Category: Pharmaceuticals Source Type: news

NPPA chief Bhupendra Singh to move to NACWC
The appointments committee of the Cabinet has appointed current NPPA chairman Bhupendra Singh to the National Authority for Chemical Weapons Convention. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2018 Category: Pharmaceuticals Source Type: news

Government to strengthen regulation of ultrasound, other imaging equipment
The move is also expected to ensure that these products follow high quality standards and are easier for the government to track in order to prevent abuse. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2018 Category: Pharmaceuticals Source Type: news

Cipla's U-turn: Happily ever after?
In a foes-turn-friends move announced on February 27, the Mumbai-based drug maker announced that it will partner Swiss biotech company Roche to promote Actemra and Syndyma. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for sedative injection
The approval from USFDA is to market Dexmedetomidine Hydrochloride injection 200 mcg (base)/ 2 ML and 100 mcg (base)/ ML single dose virals, Zydus Cadila said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 28, 2018 Category: Pharmaceuticals Source Type: news

Roche and Cipla tie up to market anti cancer drugs
Roche said this partnership will also enable it to focus on bringing new, transformative medicines to patients in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 28, 2018 Category: Pharmaceuticals Source Type: news

Can pharma learn from auto? Of course!
The drug industry is facing threats from unexpected rivals such as Google and Samsung, while the auto sector is grappling with new-age nemeses like Google and Tesla. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 28, 2018 Category: Pharmaceuticals Source Type: news

Cipla ties up with Roche to sell 2 cancer drugs in India
The pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2018 Category: Pharmaceuticals Source Type: news

Shantha Biotechnics gets WHO nod for cholera vaccine
The vaccine is the second “mass campaign” vaccine and first cholera vaccine worldwide to receive such a stamp of approval for storage and distribution outside the traditional cold chain. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2018 Category: Pharmaceuticals Source Type: news

Is Sun Pharma's Halol site close to a rebound?
About 40% of the US revenues of Sun Pharmaceutical Industries, India's most valuable pharmaceutical company, is linked to its Halol site. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets EIR from USFDA for Srikakulam plant
Dr Reddy's today said it has received the establishment inspection report (EIR) from the USFDA for its its formulations facility in Srikakulam, Andhra Pradesh. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2018 Category: Pharmaceuticals Source Type: news

Telangana to lobby for pharma industry with Centre
Telangana industries minister KT Rama Rao pointed out that the pharma industry ’s growth rate fell to 5.5% in the past two years while the country’s gross domestic product (GDP) grew by 7%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 24, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma gets 3 observations from USFDA for Halol plant
The United States Food and Drug Administration (USFDA) conducted the Good Manufacturing Practices (GMP) inspection of the company's Halol facility from February 12-23, 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 23, 2018 Category: Pharmaceuticals Source Type: news

SPARC gets I-T dept demand notice for Rs 27.30 crore
The company is contesting the demand and would file an appropriate appeal against this order within the stipulated period. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 23, 2018 Category: Pharmaceuticals Source Type: news

Working to resolve issues, say Singh Brothers
"We assure that we are NOT going anywhere and are addressing the issues with responsibility and sincerity," the Singh brothers said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2018 Category: Pharmaceuticals Source Type: news

Price control on stents to continue: Govt
Industry asked to be prepared to meet demand for medical devices, even as the Centre is laying grounds for the launch of its mega healthcare scheme. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2018 Category: Pharmaceuticals Source Type: news

Brinton pharma in talks with VCs to raise up to Rs 150 crore
The company is on the road to raise further capital and has hired investment bank Citadel Securities to look for investors, ” said one of the persons with direct knowledge of the company’s plans. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2018 Category: Pharmaceuticals Source Type: news

NPPA not to stop withdrawal of stents from market
The authority had asked the companies to consider options for price revision before deciding to withdraw their products from the market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma recalls over 17.5 K bottles of nasal spray from US
Sun Pharmaceutical Industries Inc is recalling 17,554 bottles of Azelastine HCl Nasal Solution (Nasal Spray) 0.1 per cent (137 mcg per spray), 30 ml. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2018 Category: Pharmaceuticals Source Type: news

Biocon gets 6 observations from USFDA for Malaysia facility
As per the US health regulator, observations are made in Form 483 when investigators feel that conditions or practices in the facility are such that products may become adulterated or render injuries to health. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma eyes European business of Apotex
The deal may be valued at around $100 million and fits in with Aurobindo ’s strategic road map of upping its presence in eastern Europe through bolt-on acquisitions, two sources told ET. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2018 Category: Pharmaceuticals Source Type: news

4 NCR hospitals jacked up prices of branded drugs 12 fold: NPPA
The hospitals have been the “major beneficiaries” of profit in all these cases because they inflated the maximum retail prices of the products, NPPA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2018 Category: Pharmaceuticals Source Type: news

Curbs on oxytocin production and trade to check misuse
Only a Bengaluru-based state-owned pharmaceutical company will manufacture the hormone in the quantity required for medical purposes, said another government official. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2018 Category: Pharmaceuticals Source Type: news

Hospitals prescribe drugs excluded from price control to boost profit: NPPA
Four hospitals in the NCR marked up the retail prices of such medicines as much as 12-fold from the rates at which they were purchased, NPPA said in a report. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 20, 2018 Category: Pharmaceuticals Source Type: news

New committee to examine safety, rationality of over 300 drugs banned since 2016
The committee will be headed by Dr Nilima Kshirsagar, chair of clinical pharmacology at the Indian Council of Medical Research, Mumbai, according to the notification. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 20, 2018 Category: Pharmaceuticals Source Type: news

Private hospitals making up to 1,737% profit on drugs, finds NPPA study
NPPA's study found that "the major beneficiaries of profits in all these cases because of inflated MRPs have been hospitals rather than drug manufacturers ”. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 20, 2018 Category: Pharmaceuticals Source Type: news

SC rejects petition by Singh brothers against Daiichi's arbitration award
Daiichi approached the high court earlier this week to enforce the award following this favourable judgment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2018 Category: Pharmaceuticals Source Type: news

Government to come out with new pharma policy: Ananth Kumar
The big healthcare initiative announced in the budget for 2018-19 seeks to cover 10 crore households requires many verticals -- infrastructure, human resources and pharma and medical device products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 15, 2018 Category: Pharmaceuticals Source Type: news

Government to bring major changes in Drug Pricing Control Order
"We will have major reforms in DPCO, that I am going to assure. We need to have reforms in DPCO. We need to come out with a new pharma policy," Kumar said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 15, 2018 Category: Pharmaceuticals Source Type: news

Sanofi bets on India with portfolio of drugs for diabetes, rare diseases
Sanofi reported one of the sharpest falls in its global sales in the fourth quarter, owing to the decline in diabetes drug sales, a controversial dengue vaccination settlement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 13, 2018 Category: Pharmaceuticals Source Type: news

The inside story of how Ajay Piramal ’s pharma empire received a boost after the Abbott sale
The domestic formulations exit was timely and generated funds that were deployed in financial services, realty and information management. Piramal continued to build on fledgling pharma segments. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2018 Category: Pharmaceuticals Source Type: news

Malvinder, Shivinder Singh move Supreme Court to challenge High Court ruling in favour of Daiichi Sankyo
The Singhs and a company controlled by them have sought the apex court ’s permission to appeal the judgement, said people familiar with the development. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2018 Category: Pharmaceuticals Source Type: news